Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 178 Total
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap20.96MEPS (ttm)-733.97
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y57.31%
P/S2096.25EPS next 5Y-
P/B3.74EPS Q/Q99.98%
Dividend271.87%Sales Q/Q-100.00%
Insider Own0.00%Inst Own0.43%
Insider Trans-Inst Trans-
Short Float0.08%EarningsMay 15/b
Analyst Recom3.00Target Price240.00
Avg Volume210.26K52W Range3.08 - 597.60
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. It operates through the United States and United Kingdom geographical segments. The company builds a biopharmaceutical business, which is focused on hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on January 5, 1996 and is headquartered in Berkeley Heights, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lazar David E.Interim CEOFeb 26 '25Sale0.03194,628,8205,507,9960Feb 28 04:48 PM
XAGE - Longevity Health Holdings Inc - Stock Price Chart
TickerXAGE [NASD]
CompanyLongevity Health Holdings Inc
CountryUSA
IndustryHousehold & Personal Products
Market Cap5.75MEPS (ttm)-11.60
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S10.27EPS next 5Y-
P/B-EPS Q/Q75.85%
Dividend-Sales Q/Q-
Insider Own16.20%Inst Own3.46%
Insider Trans0.00%Inst Trans-9.69%
Short Float4.78%Earnings-
Analyst Recom-Target Price-
Avg Volume519.54K52W Range2.20 - 59.10
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its cosmetic product lines include Carmell Secretome and Elevai Exosomes, that support skin and hair health. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Upton Richard ADirectorSep 13 '24Buy0.475,0002,33615,000Sep 16 04:30 PM
Gregory KathrynDirectorSep 06 '24Buy0.511,26064322,500Sep 10 04:30 PM
Sturgeon Patrick ADirectorSep 06 '24Buy0.511,26164318,051Sep 10 04:30 PM
Cassaday Bryan J.Chief Financial OfficerSep 10 '24Buy0.464752184,250Sep 10 04:30 PM
Frisch Scott M.DirectorSep 06 '24Buy0.511,0095157,598Sep 10 04:30 PM
PLRZ - Polyrizon Ltd - Stock Price Chart
TickerPLRZ [NASD]
CompanyPolyrizon Ltd
CountryIsrael
IndustryBiotechnology
Market Cap6.20MEPS (ttm)-92.09
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.00EPS Q/Q-133.99%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own5.26%
Insider Trans-Inst Trans-75.77%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.83M52W Range0.55 - 1200.00
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.
KAPA - Kairos Pharma Ltd - Stock Price Chart
TickerKAPA [AMEX]
CompanyKairos Pharma Ltd
CountryUSA
IndustryBiotechnology
Market Cap19.46MEPS (ttm)-0.25
P/E-EPS this Y7.25%
Forward P/E-EPS next Y-60.94%
PEG-EPS past 5Y-23.37%
P/S-EPS next 5Y-24.45%
P/B2.56EPS Q/Q-216.73%
Dividend-Sales Q/Q-
Insider Own57.73%Inst Own9.36%
Insider Trans0.00%Inst Trans1.46%
Short Float3.39%EarningsMay 28
Analyst Recom1.00Target Price8.33
Avg Volume887.64K52W Range0.40 - 4.00
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murali RamachandranVP of Research and DevelopmentNov 25 '24Buy1.59200318133,057Nov 25 08:30 PM
Samuelson DougChief Financial OfficerNov 22 '24Buy1.502,5003,75060,796Nov 25 06:03 AM
Yu John SCEO and ChairmanNov 20 '24Buy1.444,0005,7605,341,837Nov 21 09:53 PM
ANPA - Rich Sparkle Holdings Ltd - Stock Price Chart
TickerANPA [NASD]
CompanyRich Sparkle Holdings Ltd
CountryHong Kong
IndustrySpecialty Business Services
Market Cap57.86MEPS (ttm)0.07
P/E63.41EPS this Y1.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.81EPS next 5Y-
P/B20.13EPS Q/Q-
Dividend-Sales Q/Q-9.10%
Insider Own67.70%Inst Own18.00%
Insider Trans0.00%Inst Trans2.25%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.52M52W Range2.80 - 14.83
Rich Sparkle Holdings is a financial printing and corporate services provider specializing in designing and printing high quality financial materials in Hong Kong. Our service portfolio covers a myriad of deliverables, including listing documents, financial reports, fund documents, circulars and announcements. We offer our customers a wide range of convenient and quality financial printing services, from typesetting, proofreading, translation, design and printing. In addition, we also offer advisory services such as conducting internal control assessment and environmental, social and governance performance evaluation as well as other services including provision of co-working space, which could cater for our customersa different requirements. Our customers include a diverse range of domestic and international companies listed on the Stock Exchange of Hong Kong as well as companies that are preparing for their initial listing on the HK Stock Exchange.
IXHL - Incannex Healthcare Inc - Stock Price Chart
TickerIXHL [NASD]
CompanyIncannex Healthcare Inc
CountryAustralia
IndustryDrug Manufacturers - Specialty & Generic
Market Cap32.74MEPS (ttm)-1.25
P/E-EPS this Y16.52%
Forward P/E-EPS next Y-62.50%
PEG-EPS past 5Y-130.90%
P/S327.39EPS next 5Y-
P/B0.84EPS Q/Q46.80%
Dividend-Sales Q/Q-
Insider Own21.94%Inst Own0.63%
Insider Trans0.00%Inst Trans4.02%
Short Float5.62%EarningsMay 15/b
Analyst Recom-Target Price-
Avg Volume65.41M52W Range0.08 - 3.12
Jun-24-25 07:30AM Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch (GlobeNewswire) +10.00%
Jun-18-25 07:30AM Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X (GlobeNewswire)
Jun-17-25 07:30AM Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy (GlobeNewswire) +5.53%
Jun-12-25 07:30AM Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution (GlobeNewswire) +14.57%
Jun-03-25 07:30AM Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program (GlobeNewswire)
May-29-25 07:30AM Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance (GlobeNewswire)
May-28-25 04:21PM Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 (Newsfile) -14.78%
07:00AM Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results (GlobeNewswire)
May-20-25 07:30AM Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution (GlobeNewswire) +20.06%
May-16-25 09:00AM Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants (GlobeNewswire)
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on July 5, 2023 and is headquartered in Norwest, Australia.
BLMZ - BloomZ Inc - Stock Price Chart
TickerBLMZ [NASD]
CompanyBloomZ Inc
CountryJapan
IndustryEntertainment
Market Cap3.14MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1366.67%
Dividend-Sales Q/Q-24.48%
Insider Own56.74%Inst Own2.20%
Insider Trans0.00%Inst Trans3.39%
Short Float5.68%Earnings-
Analyst Recom-Target Price-
Avg Volume29.47M52W Range0.06 - 4.30
BloomZ, Inc. is an audio producing and voice actor managing company. It offers audio production and voice acting educational services. It operates through audio production, VTuber management and voice actor workshop business lines. The Audio Production business provides audio production services for animations and video games. The VTuber Management business includes a virtual animated character with motion-capture technology. The Voice Actor Workshop business offers professional and practical voice acting educational services. The company was founded by Kazusa Esaki on October 17, 2017 and is headquartered in Tokyo, Japan.
ZEPP - Zepp Health Corporation ADR - Stock Price Chart
TickerZEPP [NYSE]
CompanyZepp Health Corporation ADR
CountryNetherlands
IndustryConsumer Electronics
Market Cap96.97MEPS (ttm)-5.01
P/E-EPS this Y52.30%
Forward P/E-EPS next Y50.00%
PEG-EPS past 5Y-
P/S0.54EPS next 5Y-
P/B0.85EPS Q/Q-36.11%
Dividend-Sales Q/Q-3.56%
Insider Own0.59%Inst Own26.06%
Insider Trans0.00%Inst Trans-7.93%
Short Float0.12%EarningsMay 20/b
Analyst Recom1.00Target Price12.34
Avg Volume376.61K52W Range2.06 - 10.69
Zepp Health Corp. engages in the development of smart wearable health and consumer fitness devices. It empowers users to achieve their well-being goals by optimizing their health, fitness, and wellness journeys. Its brands include Amazfit, Zepp Clarity, and Zepp Aura. The company was founded by Huang Wang in 2013 and is headquartered in Gorinchem, Netherlands.
PTNM - Pitanium Ltd - Stock Price Chart
TickerPTNM [NASD]
CompanyPitanium Ltd
CountryHong Kong
IndustryInternet Retail
Market Cap306.72MEPS (ttm)0.06
P/E242.33EPS this Y-11.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S31.95EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own85.50%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float1.20%Earnings-
Analyst Recom-Target Price-
Avg Volume1.57M52W Range3.52 - 10.55
Pitanium's Operating Subsidiary is a retailer in Hong Kong focusing on the sale of its proprietary brand products, namely PITANIUM and BIG PI online. It also generates revenue from the offline sale at six retail stores situated in Hong Kongas premier shopping destinations. The brand "PITANIUM" was launched in 2019 and began by offering high-end skincare and haircare solutions to spas in Hong Kong. These brand products were later offered for sale to retail customers in our online shop, which allows customers to enjoy the use of professional skincare and personal care products in the comfort of their homes, thereby promoting their health and well-being. The brand "BIG PI" was launched in 2023 and offers whole sets of products to its retail customers using different product formulas.
ZKIN - ZK International Group Co Ltd - Stock Price Chart
TickerZKIN [NASD]
CompanyZK International Group Co Ltd
CountryChina
IndustrySteel
Market Cap14.66MEPS (ttm)-0.57
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.14EPS next 5Y-
P/B0.52EPS Q/Q96.62%
Dividend-Sales Q/Q-10.71%
Insider Own27.25%Inst Own0.41%
Insider Trans0.00%Inst Trans22.26%
Short Float1.31%Earnings-
Analyst Recom-Target Price-
Avg Volume2.48M52W Range0.82 - 6.30
May-21-25 08:30AM ZK International Launches Unique Financing Strategy as Public Market Gateway for Crypto's Viral Movement -- Targeting Billion Dollar XRP Community via ZKIN Warrants (PR Newswire) -20.34%
Feb-24-25 09:00AM ZK International Group Co., Ltd. Resolves Nasdaq Bid Price Deficiency and Remains in Compliance with Nasdaq Listing Standards (PR Newswire)
Feb-07-25 04:00PM ZK International Postpones Shareholder Call (PR Newswire) -16.67%
Jan-31-25 09:00AM ZK International's xSigma Corp. Plans to Launch xSigma Wallet: A Crypto Platform for Buying Memecoins & Digital Assets with Credit Cards (PR Newswire) +16.78%
Jan-29-25 09:00AM ZK International Group Announces 1-for-7 Reverse Stock Split (PR Newswire) -40.70%
Jan-28-25 08:00AM ZK International Group Co., Ltd. Announces Shareholder Call to Discuss Upcoming News and Strategic Growth Plans (PR Newswire) +20.40%
Jan-27-25 04:00PM ZK International Group Announces 405% Gross Profit Increase for the Fiscal Year 2024 (PR Newswire)
Nov-13-24 08:30AM ZK International Group Seeks to Accept Cryptocurrency Payments to Enhance Global Supplier, Vendor, and Customer Transactions (PR Newswire) +25.68%
Oct-03-24 07:45AM ZK International Group's Breakthrough Win in the Shenzhen Gas Project is Expected to Propel Growth Amid China's Economic Stimulus Which Should Exceed $284 Billion (PR Newswire) +10.99%
Sep-30-24 04:10PM ZK International Group Co., Ltd. Announces Record Revenue of $52.89 Million, an Increase of 6.5% for the First Half of Fiscal Year 2024 (PR Newswire) +14.42% +10.51%
ZK International Group Co., Ltd. is a holding company, which engages in the manufacture and sales of stainless steel band, copper strip, welded stainless steel pipes and fittings, valve, light industry machinery equipment, and other stainless steel products. The company was founded by Jian Cong Huang and Guo Lin Wang on May 13, 2015 and is headquartered in Wenzhou, China.
1234561018